vs
Side-by-side financial comparison of ADMA BIOLOGICS, INC. (ADMA) and SHENANDOAH TELECOMMUNICATIONS CO (SHEN). Click either name above to swap in a different company.
ADMA BIOLOGICS, INC. is the larger business by last-quarter revenue ($139.2M vs $91.6M, roughly 1.5× SHENANDOAH TELECOMMUNICATIONS CO). ADMA BIOLOGICS, INC. runs the higher net margin — 35.5% vs -5.9%, a 41.3% gap on every dollar of revenue. On growth, ADMA BIOLOGICS, INC. posted the faster year-over-year revenue change (18.4% vs 7.2%). ADMA BIOLOGICS, INC. produced more free cash flow last quarter ($34.6M vs $-78.6M). Over the past eight quarters, ADMA BIOLOGICS, INC.'s revenue compounded faster (30.4% CAGR vs 15.0%).
ADMA Biologics Inc. is a biopharmaceutical enterprise focused on the research, development, manufacturing and commercialization of specialty plasma-derived immunoglobulin therapies. It primarily operates in the United States, catering to patients with primary immunodeficiency and other immune-related disorders, healthcare providers and medical institutions across its core immune health therapeutic segment.
Shenandoah Telecommunications Co is a U.S. regional telecom provider offering broadband internet, wireless voice/data services, digital cable TV, and fiber-optic solutions. It serves residential, small business and enterprise clients across Mid-Atlantic states, focusing on underserved rural and suburban markets in Virginia, West Virginia, Maryland and Pennsylvania.
ADMA vs SHEN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $139.2M | $91.6M |
| Net Profit | $49.4M | $-5.4M |
| Gross Margin | 63.8% | — |
| Operating Margin | 45.1% | -1.0% |
| Net Margin | 35.5% | -5.9% |
| Revenue YoY | 18.4% | 7.2% |
| Net Profit YoY | -55.9% | -95.8% |
| EPS (diluted) | $0.20 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $139.2M | $91.6M | ||
| Q3 25 | $134.2M | $89.8M | ||
| Q2 25 | $122.0M | $88.6M | ||
| Q1 25 | $114.8M | $87.9M | ||
| Q4 24 | $117.5M | $85.4M | ||
| Q3 24 | $119.8M | $87.6M | ||
| Q2 24 | $107.2M | $85.8M | ||
| Q1 24 | $81.9M | $69.2M |
| Q4 25 | $49.4M | $-5.4M | ||
| Q3 25 | $36.4M | $-9.4M | ||
| Q2 25 | $34.2M | $-9.0M | ||
| Q1 25 | $26.9M | $-9.1M | ||
| Q4 24 | $111.9M | $-2.7M | ||
| Q3 24 | $35.9M | $-5.3M | ||
| Q2 24 | $32.1M | $-12.9M | ||
| Q1 24 | $17.8M | $214.7M |
| Q4 25 | 63.8% | — | ||
| Q3 25 | 56.3% | — | ||
| Q2 25 | 55.1% | — | ||
| Q1 25 | 53.2% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 49.8% | — | ||
| Q2 24 | 53.6% | — | ||
| Q1 24 | 47.8% | — |
| Q4 25 | 45.1% | -1.0% | ||
| Q3 25 | 38.0% | -8.0% | ||
| Q2 25 | 35.1% | -10.3% | ||
| Q1 25 | 30.4% | -6.9% | ||
| Q4 24 | 32.6% | -6.7% | ||
| Q3 24 | 33.1% | -4.8% | ||
| Q2 24 | 36.6% | -18.5% | ||
| Q1 24 | 26.7% | -4.0% |
| Q4 25 | 35.5% | -5.9% | ||
| Q3 25 | 27.1% | -10.5% | ||
| Q2 25 | 28.1% | -10.2% | ||
| Q1 25 | 23.4% | -10.4% | ||
| Q4 24 | 95.2% | -3.2% | ||
| Q3 24 | 30.0% | -6.0% | ||
| Q2 24 | 29.9% | -15.0% | ||
| Q1 24 | 21.7% | 310.0% |
| Q4 25 | $0.20 | $-0.13 | ||
| Q3 25 | $0.15 | $-0.20 | ||
| Q2 25 | $0.14 | $-0.19 | ||
| Q1 25 | $0.11 | $-0.19 | ||
| Q4 24 | $0.45 | $-0.34 | ||
| Q3 24 | $0.15 | $-0.13 | ||
| Q2 24 | $0.13 | $-0.24 | ||
| Q1 24 | $0.08 | $4.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $87.6M | $27.3M |
| Total DebtLower is stronger | $72.1M | $642.4M |
| Stockholders' EquityBook value | $477.3M | $880.8M |
| Total Assets | $624.2M | $1.9B |
| Debt / EquityLower = less leverage | 0.15× | 0.73× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.6M | $27.3M | ||
| Q3 25 | $61.4M | $22.6M | ||
| Q2 25 | $90.3M | $29.1M | ||
| Q1 25 | $71.6M | $87.5M | ||
| Q4 24 | $103.1M | $46.3M | ||
| Q3 24 | $86.7M | $43.1M | ||
| Q2 24 | $88.2M | $43.8M | ||
| Q1 24 | $45.3M | $389.7M |
| Q4 25 | $72.1M | $642.4M | ||
| Q3 25 | $72.4M | $535.4M | ||
| Q2 25 | — | $513.1M | ||
| Q1 25 | — | $515.8M | ||
| Q4 24 | $72.3M | $418.0M | ||
| Q3 24 | — | $345.2M | ||
| Q2 24 | — | $297.4M | ||
| Q1 24 | — | $298.7M |
| Q4 25 | $477.3M | $880.8M | ||
| Q3 25 | $431.2M | $892.7M | ||
| Q2 25 | $398.3M | $902.0M | ||
| Q1 25 | $373.4M | $910.5M | ||
| Q4 24 | $349.0M | $918.6M | ||
| Q3 24 | $231.9M | $925.4M | ||
| Q2 24 | $188.3M | $933.1M | ||
| Q1 24 | $153.7M | $871.6M |
| Q4 25 | $624.2M | $1.9B | ||
| Q3 25 | $568.7M | $1.9B | ||
| Q2 25 | $558.4M | $1.8B | ||
| Q1 25 | $510.6M | $1.8B | ||
| Q4 24 | $488.7M | $1.7B | ||
| Q3 24 | $390.6M | $1.7B | ||
| Q2 24 | $376.4M | $1.7B | ||
| Q1 24 | $350.9M | $1.4B |
| Q4 25 | 0.15× | 0.73× | ||
| Q3 25 | 0.17× | 0.60× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | 0.57× | ||
| Q4 24 | 0.21× | 0.46× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.32× | ||
| Q1 24 | — | 0.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.6M | $28.8M |
| Free Cash FlowOCF − Capex | $34.6M | $-78.6M |
| FCF MarginFCF / Revenue | 24.8% | -85.8% |
| Capex IntensityCapex / Revenue | 0.8% | 117.2% |
| Cash ConversionOCF / Net Profit | 0.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $27.8M | $-257.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.6M | $28.8M | ||
| Q3 25 | $13.3M | $30.7M | ||
| Q2 25 | $21.1M | $20.9M | ||
| Q1 25 | $-19.7M | $20.5M | ||
| Q4 24 | $50.2M | $20.6M | ||
| Q3 24 | $25.0M | $24.3M | ||
| Q2 24 | $45.6M | $2.5M | ||
| Q1 24 | $-2.2M | $15.2M |
| Q4 25 | $34.6M | $-78.6M | ||
| Q3 25 | $-1.1M | $-51.4M | ||
| Q2 25 | $18.7M | $-65.3M | ||
| Q1 25 | $-24.4M | $-62.7M | ||
| Q4 24 | $47.5M | $-72.0M | ||
| Q3 24 | $24.0M | $-51.3M | ||
| Q2 24 | $43.6M | $-78.3M | ||
| Q1 24 | $-4.6M | $-54.9M |
| Q4 25 | 24.8% | -85.8% | ||
| Q3 25 | -0.8% | -57.2% | ||
| Q2 25 | 15.3% | -73.7% | ||
| Q1 25 | -21.2% | -71.3% | ||
| Q4 24 | 40.4% | -84.3% | ||
| Q3 24 | 20.0% | -58.5% | ||
| Q2 24 | 40.7% | -91.3% | ||
| Q1 24 | -5.6% | -79.3% |
| Q4 25 | 0.8% | 117.2% | ||
| Q3 25 | 10.7% | 91.4% | ||
| Q2 25 | 2.0% | 97.3% | ||
| Q1 25 | 4.1% | 94.7% | ||
| Q4 24 | 2.3% | 108.4% | ||
| Q3 24 | 0.9% | 86.2% | ||
| Q2 24 | 1.9% | 94.2% | ||
| Q1 24 | 2.9% | 101.2% |
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | -0.73× | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | -0.12× | 0.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
SHEN
| Residential And SMB Incumbent Broadband | $41.5M | 45% |
| Residential And SMB Glo Fiber Expansion Markets | $23.0M | 25% |
| Commercial Fiber | $20.3M | 22% |
| RLEC Other | $6.8M | 7% |
